Edition:
United States

DarioHealth Corp (DRIO.OQ)

DRIO.OQ on NASDAQ Stock Exchange Capital Market

1.40USD
4:00pm EDT
Change (% chg)

$-0.06 (-4.11%)
Prev Close
$1.46
Open
$1.47
Day's High
$1.55
Day's Low
$1.40
Volume
123,413
Avg. Vol
27,907
52-wk High
$3.64
52-wk Low
$1.32

Chart for

About

DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company's product, Dario, also known as Dario Smart Diabetes... (more)

Overall

Beta: -1.83
Market Cap(Mil.): $24.11
Shares Outstanding(Mil.): 16.74
Dividend: --
Yield (%): --

Financials

  DRIO.OQ Industry Sector
P/E (TTM): -- 41.24 33.54
EPS (TTM): -0.87 -- --
ROI: -249.23 14.38 13.09
ROE: -254.70 17.60 15.10

BRIEF-DarioHealth Corp Reports Quarterly Loss Per Share Of $0.20

* QUARTERLY LOSS PER SHARE $0.20 Source text for Eikon: Further company coverage:

May 15 2018

BRIEF-Dariohealth Corp Says Selling Stockholders May Offer From Time To Time Up To 8.5 Mln shares

* DARIOHEALTH CORP SAYS SELLING STOCKHOLDERS MAY OFFER FROM TIME TO TIME UP TO 8.5 MILLION SHARES OF CO'S COMMON STOCK - SEC FILING Source text for Eikon: (http://bit.ly/2Fkuvtb) Further company coverage:

Apr 26 2018

BRIEF-DarioHealth Receives U.S. FDA Clearance For iPhone 7, 8 And iPhone X Smart Glucose Meter

* DARIOHEALTH RECEIVES U.S. FDA CLEARANCE FOR IPHONE 7, 8 AND IPHONE X SMART GLUCOSE METER Source text for Eikon: Further company coverage:

Mar 26 2018

BRIEF-DarioHealth Reports Fourth Quarter And Year End 2017 Results

* DARIOHEALTH REPORTS FOURTH QUARTER AND YEAR END 2017 RESULTS

Mar 19 2018

BRIEF-DarioHealth Says Qtrly Reports On Form 10-Q For Quarter Ended March 30, 2017, June 30, 2017 And Sept 30, 2017 Should No Longer Be Relied Upon​

* DARIOHEALTH - QTRLY REPORTS ON FORM 10-Q FOR QUARTER ENDED MARCH 30, 2017, JUNE 30, 2017 AND SEPT 30, 2017 FILED WITH SEC SHOULD NO LONGER BE RELIED UPON​

Mar 19 2018

BRIEF-Dariohealth Launches Sales Of Dario Blood Glucose Monitoring System On Amazon Prime

* DARIOHEALTH LAUNCHES SALES OF DARIO™ BLOOD GLUCOSE MONITORING SYSTEM ON AMAZON PRIME

Feb 20 2018

BRIEF-DarioHealth Wins Key Contract In Clinical Study

* DARIOHEALTH WINS KEY CONTRACT ENSURING ITS PLATFORM TO BE UTILIZED IN CLINICAL STUDY

Feb 08 2018

Competitors

Earnings vs. Estimates